Director/PDMR Shareholding

RNS Number : 9086P
Origin Enterprises Plc
15 October 2019
 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

Christopher Richards

2

Reason for the notification

 

a)

Position/status

Non-Executive Director / PDMR

 

b)

Initial Notification Amendment

Initial Notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Origin Enterprises plc

 

b)

LEI

213800AIB4U7N5BLS350

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

Origin Enterprises plc Ordinary Shares of €0.01 each

 

 

 

 

IE00B1WV4493

b)

Nature of the transaction  

Purchase of Shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

€4.60

4,275

 

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transaction

 

 

 

e)

Date of the transaction

14 October 2019

 

f)

Place of the transaction

Dublin, Ireland

 

g)

Additional Information

Following the transaction disclosed here Christopher Richards beneficially owns 7,680 ordinary shares of €0.01 each in Origin Enterprises plc representing 0.006% of the company's issued share capital.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLIFSTIFLELIA
UK 100

Latest directors dealings